查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417401

全球下游製程市场：趋势、预测与竞争分析（~2030 年）

Downstream Processing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年，全球下游加工市场规模预计将达536亿美元，2024年至2030年复合年增长率为13.2%。该市场的主要驱动力包括生物製药领域研发支出的成长、对生物製药的需求不断增长、膜过滤的使用增加以及浓缩技术在疫苗和生物製药生产中的重要性。全球下游加工市场前景广阔，生物製药製造商和受託製造厂商市场蕴藏机会。

下游加工市场洞察

Lucintel 预测，由于下游精製技术在製造一流产品方面取得了进步，疫苗製造在预测期内仍将是最大的细分市场。

在这个市场中，由于老龄化人口对生物製药的需求不断增长，生物製药製造商将继续成为最大的细分市场。

由于政府支持力度加大、研发基础设施日趋成熟以及专业知识和学术成果水准不断提高，亚太地区预计将在预测期内实现最高成长。

常问问题

Q1.市场规模有多大？

A1. 至2030年，全球下游加工市场预计将达到536亿美元。

Q2.市场成长预测如何？

A2. 2024年至2030年，全球下游加工市场预计复合年增长率为13.2%。

Q3.影响市场成长的主要驱动因素有哪些？

A3. 该市场的主要驱动力是生物製药领域研发支出的成长、对生物製药的需求不断增长、膜过滤的使用增加以及浓缩技术在疫苗和生物製药生产中的重要性。

Q4.市场的主要细分市场是什么？

A4. 下游加工市场前景广阔，为生物製药製造商和受託製造厂商市场带来机会。

Q5.市场上主要企业有哪些？

A5.主要下游加工企业如下。

  • Thermo Fisher Scientific
  • GE Healthcare
  • Sartorius Stedim Biotech
  • Merck Millipore
  • Danaher
  • 3M
  • Boehringer Ingelheim
  • Lonza
  • Eppendorf
  • Finesse Solutions

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，由于製造一流产品的下游精製技术的进步，疫苗製造在预测期内仍将是其最大的部分。

Q7. 未来五年预计哪个地区将成为最大的市场？

A7. 由于政府支持力度加大、研发基础设施日趋成熟以及专业知识和学术成果水平不断提高，亚太地区预计将在预测期内实现最高增长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球下游加工市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势与预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球下游製程市场趋势（2018-2023）与预测（2024-2030）
  • 全球下游加工市场：依技术分类
    • 精製
    • 固液分离
    • 澄清/浓缩
  • 全球下游加工市场：依产品分类
    • 层析管柱/树脂
    • 筛选
    • 膜吸附剂
    • 一次性产品
    • 其他的
  • 全球下游加工市场：依应用分类
    • 单株抗体生产
    • 疫苗生产
    • 胰岛素产生
    • 免疫球蛋白生产
    • 促血红细胞生长素的产生
    • 其他的
  • 全球下游加工市场：依最终用途产业
    • 生物製药製造商
    • 契约製造组织
    • 其他的

第四章市场趋势与预测分析：按地区（2018-2030）

  • 全球下游加工市场：按地区
  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 依技术
    • 副产品
    • 按用途
    • 按最终用途行业
    • 按地区
  • 全球下游加工市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球下游加工市场的产能
    • 全球下游加工市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Thermo Fisher Scientific
  • GE Healthcare
  • Sartorius Stedim Biotech
  • Merck Millipore
  • Danaher
  • 3M
  • Boehringer Ingelheim
  • Lonza
  • Eppendorf
  • Finesse Solutions
简介目录

Downstream Processing Trends and Forecast

The future of the global downstream processing market looks promising with opportunities in the biopharmaceutical manufacturers and contract manufacturing organizations markets. The global downstream processing market is expected to reach an estimated $53.6 billion by 2030 with a CAGR of 13.2% from 2024 to 2030. The major drivers for this market are growth of research and development spending in the biopharmaceutical sector, growing demand for biopharmaceuticals, and growing use of membrane filtration for sterilizing and the significance of concentration techniques for the manufacturing of vaccines and biopharmaceuticals.

A more than 150-page report is developed to help in your business decisions.

Downstream Processing by Segment

The study includes a forecast for the global downstream processing by technique, product, application, end use industry, and region.

Downstream Processing Market by Technique [Shipment Analysis by Value from 2018 to 2030]:

  • Purification
  • Solid-Liquid Separation
  • Clarification/Concentration

Downstream Processing Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Chromatography Columns & Resins
  • Filters
  • Membrane Adsorbers
  • Single-Use Products
  • Others

Downstream Processing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Monoclonal Antibody Production
  • Vaccine Production
  • Insulin Production
  • Immunoglobulin Production
  • Erythropoietin Production
  • Others

Downstream Processing Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Biopharmaceutical Manufacturers
  • Contract Manufacturing Organizations
  • Otherss

Downstream Processing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Downstream Processing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies downstream processing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the downstream processing companies profiled in this report include-

  • Thermo Fisher Scientific
  • GE Healthcare
  • Sartorius Stedim Biotech
  • Merck Millipore
  • Danaher
  • 3M
  • Boehringer Ingelheim
  • Lonza
  • Eppendorf
  • Finesse Solutions

Downstream Processing Market Insights

Lucintel forecasts that vaccine production will remain the largest segment over the forecast period due to advancements in downstream purification technology for the production of top-tier products.

Within this market, biopharmaceutical manufacturers will remain the largest segment due to rising need for biopharmaceuticals among the elderly demographic.

APAC is expected to witness highest growth over the forecast period due to rising governmental backing, the maturation of R&D infrastructure, and the increasing level of expertise and academic achievements.

Features of the Global Downstream Processing Market

Market Size Estimates: Downstream processing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Downstream processing market size by various segments, such as by technique, product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Downstream processing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technique, product, application, end use industry, and regions for the downstream processing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the downstream processing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the downstream processing market size?

Answer: The global downstream processing market is expected to reach an estimated $53.6 billion by 2030.

Q2. What is the growth forecast for downstream processing market?

Answer: The global downstream processing market is expected to grow with a CAGR of 13.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the downstream processing market?

Answer: The major drivers for this market are growth of research and development spending in the biopharmaceutical sector, growing demand for biopharmaceuticals, and growing use of membrane filtration for sterilizing and the significance of concentration techniques for the manufacturing of vaccines and biopharmaceuticals.

Q4. What are the major segments for downstream processing market?

Answer: The future of the downstream processing market looks promising with opportunities in the biopharmaceutical manufacturers and contract manufacturing organizations markets.

Q5. Who are the key downstream processing market companies?

Answer: Some of the key downstream processing companies are as follows.

  • Thermo Fisher Scientific
  • GE Healthcare
  • Sartorius Stedim Biotech
  • Merck Millipore
  • Danaher
  • 3M
  • Boehringer Ingelheim
  • Lonza
  • Eppendorf
  • Finesse Solutions

Q6. Which downstream processing market segment will be the largest in future?

Answer: Lucintel forecasts that vaccine production will remain the largest segment over the forecast period due to advancements in downstream purification technology for the production of top-tier products.

Q7. In downstream processing market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising governmental backing, the maturation of R&D infrastructure, and the increasing level of expertise and academic achievements.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the downstream processing market by technique (purification, solid-liquid separation, and clarification/concentration), product (chromatography columns & resins, filters, membrane adsorbers, single-use products, and others), application (monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and others), end use industry (biopharmaceutical manufacturers, contract manufacturing organizations, and otherss), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Downstream Processing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Downstream Processing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Downstream Processing Market by Technique
    • 3.3.1: Purification
    • 3.3.2: Solid-Liquid Separation
    • 3.3.3: Clarification/Concentration
  • 3.4: Global Downstream Processing Market by Product
    • 3.4.1: Chromatography Columns & Resins
    • 3.4.2: Filters
    • 3.4.3: Membrane Adsorbers
    • 3.4.4: Single-Use Products
    • 3.4.5: Others
  • 3.5: Global Downstream Processing Market by Application
    • 3.5.1: Monoclonal Antibody Production
    • 3.5.2: Vaccine Production
    • 3.5.3: Insulin Production
    • 3.5.4: Immunoglobulin Production
    • 3.5.5: Erythropoietin Production
    • 3.5.6: Others
  • 3.6: Global Downstream Processing Market by End Use Industry
    • 3.6.1: Biopharmaceutical Manufacturers
    • 3.6.2: Contract Manufacturing Organizations
    • 3.6.3: Otherss

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Downstream Processing Market by Region
  • 4.2: North American Downstream Processing Market
    • 4.2.2: North American Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss
  • 4.3: European Downstream Processing Market
    • 4.3.1: European Downstream Processing Market by Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
    • 4.3.2: European Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss
  • 4.4: APAC Downstream Processing Market
    • 4.4.1: APAC Downstream Processing Market by Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
    • 4.4.2: APAC Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss
  • 4.5: ROW Downstream Processing Market
    • 4.5.1: ROW Downstream Processing Market by Application: Monoclonal Antibody Production, Vaccine Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production, and Others
    • 4.5.2: ROW Downstream Processing Market by End Use Industry: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations, and Otherss

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Downstream Processing Market by Technique
    • 6.1.2: Growth Opportunities for the Global Downstream Processing Market by Product
    • 6.1.3: Growth Opportunities for the Global Downstream Processing Market by Application
    • 6.1.4: Growth Opportunities for the Global Downstream Processing Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Downstream Processing Market by Region
  • 6.2: Emerging Trends in the Global Downstream Processing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Downstream Processing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Downstream Processing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: GE Healthcare
  • 7.3: Sartorius Stedim Biotech
  • 7.4: Merck Millipore
  • 7.5: Danaher
  • 7.6: 3M
  • 7.7: Boehringer Ingelheim
  • 7.8: Lonza
  • 7.9: Eppendorf
  • 7.10: Finesse Solutions